TR200102786T2 - Sıgara bırakmaya yardımcı yöntem. - Google Patents

Sıgara bırakmaya yardımcı yöntem.

Info

Publication number
TR200102786T2
TR200102786T2 TR2001/02786T TR200102786T TR200102786T2 TR 200102786 T2 TR200102786 T2 TR 200102786T2 TR 2001/02786 T TR2001/02786 T TR 2001/02786T TR 200102786 T TR200102786 T TR 200102786T TR 200102786 T2 TR200102786 T2 TR 200102786T2
Authority
TR
Turkey
Prior art keywords
cessation
auxiliary method
hydrates
methyl
independently
Prior art date
Application number
TR2001/02786T
Other languages
English (en)
Inventor
Carl Mendel M.
Graham Stephan
Rotherham Neil
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of TR200102786T2 publication Critical patent/TR200102786T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu bulus sigaryi birakmayi saglayan bir yöntem olup, özelligi formül i'e uygun bilesikten yada bunun farmasötik açidan kabul edilebilir tuzlarindan veya hidratlarindan terapötik açidan etkili bir miktarinin verilmesini içermesidir, burada R1, ve R2 birbirinden bagimsiz olarak H veya metildir.
TR2001/02786T 1999-01-20 2000-01-19 Sıgara bırakmaya yardımcı yöntem. TR200102786T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11668199P 1999-01-20 1999-01-20
US14824699P 1999-08-11 1999-08-11

Publications (1)

Publication Number Publication Date
TR200102786T2 true TR200102786T2 (tr) 2002-05-21

Family

ID=26814491

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2001/02786T TR200102786T2 (tr) 1999-01-20 2000-01-19 Sıgara bırakmaya yardımcı yöntem.
TR2001/02999T TR200102999T2 (tr) 1999-01-20 2000-01-19 Sigarayı bırakma

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2001/02999T TR200102999T2 (tr) 1999-01-20 2000-01-19 Sigarayı bırakma

Country Status (19)

Country Link
EP (1) EP1150672A1 (tr)
JP (1) JP2002535273A (tr)
KR (1) KR20010111254A (tr)
CN (1) CN1355696A (tr)
AU (1) AU2730800A (tr)
BG (1) BG105820A (tr)
BR (1) BR0007633A (tr)
CA (1) CA2359564A1 (tr)
CZ (1) CZ20012662A3 (tr)
HU (1) HUP0105431A3 (tr)
ID (1) ID30432A (tr)
IL (1) IL144390A0 (tr)
MX (1) MXPA01007388A (tr)
NO (1) NO20013575L (tr)
NZ (1) NZ513638A (tr)
PL (1) PL349002A1 (tr)
SK (1) SK10312001A3 (tr)
TR (2) TR200102786T2 (tr)
WO (1) WO2000043002A1 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01009404A (es) * 1999-03-19 2004-03-19 Abbott Gmbh & Co Kg Metodo para tratar trastornos de alimentacion.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤

Also Published As

Publication number Publication date
NO20013575D0 (no) 2001-07-19
CA2359564A1 (en) 2000-07-27
HUP0105431A2 (en) 2002-08-28
WO2000043002A1 (en) 2000-07-27
MXPA01007388A (es) 2002-07-22
NO20013575L (no) 2001-09-11
NZ513638A (en) 2001-09-28
TR200102999T2 (tr) 2002-04-22
CN1355696A (zh) 2002-06-26
KR20010111254A (ko) 2001-12-17
SK10312001A3 (sk) 2002-03-05
ID30432A (id) 2001-12-06
CZ20012662A3 (cs) 2002-08-14
BG105820A (en) 2002-06-28
IL144390A0 (en) 2002-05-23
AU2730800A (en) 2000-08-07
BR0007633A (pt) 2002-01-02
EP1150672A1 (en) 2001-11-07
PL349002A1 (en) 2002-06-17
HUP0105431A3 (en) 2003-05-28
JP2002535273A (ja) 2002-10-22

Similar Documents

Publication Publication Date Title
BG106585A (en) Kinase inhibitors as therapeutic agents
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ATE440603T1 (de) 8-hydroxychinolinderivate
ATE297203T1 (de) Antithrombotische mitteln
BG106586A (en) Pyrazolopyramidines as therapeutic agents
DE69720773D1 (de) SAUERSTOFF ODER SCHWEFEL ENTHALTENDE 5-GLIEDRIGE HETEROAROMATISHE DERIVATIVE ALS FACTOR Xa HEMMER
LU90856I2 (fr) Uprima - apomorphine hydrochloride et ses d-riv-s pharmaceutiquement acceptables
ATE283253T1 (de) Substituierte aminopropoxyarylderivate als lxr agonisten
UY26512A1 (es) Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
AP2002002637A0 (en) Novel piperazine
TR200100432T2 (tr) Hepatit C inhibitörü tri-peptidler
AU1676200A (en) Polyhydroxylated heterocyclic derivatives as anti-coagulants
DK1140918T3 (da) Thrombininhibitorer
NZ514453A (en) Novel sulfonamide compounds and uses thereof
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
IL133627A0 (en) Antithrombotic agents
TR200101120T2 (tr) Serin proteaz inhibitörü
MXPA02009706A (es) Metodo para sintesis de perindopril y sus sales farmaceuticamente aceptables.
BG104740A (en) Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists
TR200002605T2 (tr) Nitrik oksit sentaz inhibitörleri olarak faydalı halojene amidino amino asit türevleri
TR200403436T2 (tr) Kristalin 1-metilkarbapenem türevleri.
BG104447A (en) Biphenylamidine derivatives
DK1056754T3 (da) Phosphatderivater af diaryl-1,3,4-oxadiazolon
TR200102786T2 (tr) Sıgara bırakmaya yardımcı yöntem.
BG106922A (bg) Хетероциклeни амидни производни